CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Polypid Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Polypid Ltd
18 Hasivim Street,
P.O Box 7126
PETAH TIKVA, 4917002  Israel Ticker: PYPDPYPD
Business Summary
Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board JacobHarel 66 12/1/2017 11/1/2017
Chief Executive Officer, Director AmirWeisberg 66 10/1/2010 10/1/2010
Chief Financial Officer, Executive Vice President Dikla C.Akselbrad 48 12/1/2016 7/1/2014
8 additional Officers and Directors records available in full report.

Business Names
Business Name
POLY
PolyPid Inc.
PolyPid Pharma SRL
PYPD

General Information
Number of Employees: 59 (As of 12/31/2023)
Outstanding Shares: 6,803,478 (As of 11/7/2024)
Shareholders: 50
Stock Exchange: NASD
Federal Tax Id: 514105923
Email Address: info@polypid.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024